• An ameloblastin C-terminus variant is present in human adipose tissue 

      Stakkestad, Øystein; Catherine, Heyward; Lyngstadaas, Ståle Petter; Medin, Tirill; Vondrasek, Jiri; Lian, Aina-Mari; Pezeshki, Gita; Reseland, Janne Elin (Heliyon;Volume 4, Issue 12, December 2018, Journal article; Peer reviewed, 2018-12-24)
      Objective: Transcriptional regulatory elements in the ameloblastin (AMBN) promoter indicate that adipogenesis may influence its expression. The objective here was to investigate if AMBN is expressed in adipose tissue, and ...
    • Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone 

      Marciuch, Anne; Birkeland, Bente; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad; Mathisen, Ida; Weimand, Bente (Peer reviewed; Journal article, 2023)
      Background and aims Recovery from substance use disorders (SUD) has traditionally been equated with abstinence. “Personal recovery” however emphasizes recovery as a unique and personal process, supported by changes in ...
    • Plasma levels of BDNF and EGF are reduced in acute stroke patients 

      Øverberg, Linda Thøring; Lugg, Elise Fritsch; Gaarder, Mona; Langhammer, Birgitta; Thommessen, Bente; Rønning, Ole Morten; Morland, Cecilie (Heliyon;Volume 8, Issue 6, e09661, Peer reviewed; Journal article, 2022-06-17)
      Stroke affects almost 14 million people worldwide each year. It is the second leading cause of death and a major cause of acquired disability. The degree of initial impairment in cognitive and motor functions greatly affects ...